Aldehyde dehydrogenase 2 polymorphism is associated with chemotherapy‐related cognitive impairment in patients with breast cancer who receive chemotherapy

BACKGROUND: Chemotherapy‐related cognitive impairment (CRCI) is a common but easily overlooked condition that markedly affects the quality of life (QOL) of patients with breast cancer. The rs671 is a common gene polymorphism of aldehyde dehydrogenase 2 (ALDH2) in Asia that is involved in aldehyde me...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Senbang, Li, Wen, Liu, Shaochun, Cai, Yinlian, Zhang, Qianqian, Tang, Lingxue, Yu, Sheng, Jing, Yanyan, Yin, Xiangxiang, Cheng, Huaidong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028021/
https://www.ncbi.nlm.nih.gov/pubmed/36200595
http://dx.doi.org/10.1002/cam4.5319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10028021/
https://www.ncbi.nlm.nih.gov/pubmed/36200595
http://dx.doi.org/10.1002/cam4.5319

Ejemplares similares